Impact of GLP-1 Therapies on Medtech Industry

This research article explores the rise of GLP-1 receptor agonists as a transformative weight loss solution and their potential to disrupt the medtech industry. It discusses the implications for medical devices and surgical procedures, highlighting the effectiveness of GLP-1s in managing obesity and related comorbidities. The article also examines the challenges and uncertainties surrounding access, compliance, and long-term impacts on healthcare systems.